<2>Vitiligo: NICE Approves Treatment that Increases Repigmentation
<3>The National Institute for Health and Care Excellence (NICE) has approved a skin colour restoring cream for vitiligo, a chronic autoimmune disease that causes areas of the skin to lose pigment. This approval marks a significant breakthrough in the treatment of vitiligo, a condition that affects over 80,000 adults and teenagers in England.
<3>Vitiligo: A Chronic Autoimmune Disease
Vitiligo is a condition in which areas of the skin lose pigment due to the progressive destruction of melanocytes. This can result in pale pink or white patches on the skin, which can appear or worsen due to factors such as illness, stress, or skin injury. Singer Michael Jackson was one of the many famous individuals who suffered from vitiligo.
<3>NICE Approves Ruxolitinib for Non-Segmental Vitiligo
NICE has recommended ruxolitinib (Opzelura, made by Incyte) for non-segmental vitiligo affecting the face in people aged 12 and over, where first line topical treatments have not worked. Non-segmental vitiligo causes symmetrical patches, and this approval represents